More than 90% of adults over 65 have at least one chronic condition and about 80% have two or more, according to the Centers for Disease Control and Prevention. Rather than simply treating ailments individually, researchers are exploring new pathways with pharmaceuticals originally designed for different purposes, targeting the cellular, metabolic and molecular drivers of
Already a Subscriber? Log in
To Continue Reading This Article
Become a Providence Business News subscriber and get immediate access to all of our premier content and much more.Learn More and Become a Subscriber
- Critical RI business news and analysis updated daily.
- 1 year of print (26 issues).
- Unlimited access to all subscriber only content on our website, on any device.
- Free email alerts.
- Annual Book of Lists Print Edition.
- All special issues produced during subscription term.
Click Here to purchase a paywall bypass link for this article
PBN Branded Content
Your Business Has Gone Global. Has Your Insurance?
A decade ago, “doing business internationally” was mostly a large-company concern. Today, a manufacturer in…
Learn More
